U.S. House · 117th Congress · H.R. 2883
Stop Stalling Access to Affordable Medications
To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Hakeem S. JeffriesD-NY-8
- Introduced
- April 28, 2021, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (8)
5 Democrats, 3 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Ken BuckR-CO-4
- David N. CicillineD-RI-1
- Carolyn B. MaloneyD-NY-12
- Jerrold NadlerD-NY-10
Signed on later
- Burgess OwensR-UT-4September 24, 2021
- Val Butler DemingsD-FL-10September 28, 2021
- Sheila Jackson LeeD-TX-18September 28, 2021
- Ted BuddR-NC-13August 12, 2022